Mildly oxidized low-density lipoproteins decrease early production of interleukin 2 and nuclear factor κB binding to DNA in activated T-lymphocytes

被引:15
作者
Caspar-Bauguil, S
Tkaczuk, J
Haure, MJ
Durand, M
Alcouffe, J
Thomsen, M
Salvayre, R
Benoist, H [1 ]
机构
[1] CHU Rangueil, Inst Louis Bugnard, INSERM U 466, F-31403 Toulouse 4, France
[2] CHU Rangueil, Immunol Lab, F-31403 Toulouse 4, France
关键词
atherosclerosis; lipoproteins; lymphokines; I kappa B; immunosuppression;
D O I
10.1042/0264-6021:3370269
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activated T-lymphocytes are found early in atherosclerosis lesions, but little is known about their role. Oxidized low-density lipoproteins (oxLDLs) are considered to be involved in the pathogenesis of the lesions, and we have previously demonstrated that oxLDLs inhibit not only interleukin (IL)-2-receptor expression on the surface of in vivro-activated T-lymphocytes but also their proliferation. We have now investigated the effect of oxLDLs on blast differentiation, on IL-2 synthesis and on the activation of the nuclear factor kappa B (NF-kappa B) system in activated lymphocytes. Mildly oxLDLs (50 and 100 mu g/ml) decreased the number of lymphoblasts and the level of IL-2 concentration in the culture supernatants after activation of lymphocytes by phytohaemagglutinin and PMA + ionomycin. The inhibition of IL-2 production was observed in the CD3(+) T-lymphocyte cytoplasm as early as 4 h after activation by PMA + ionomycin. The study of NF-KB showed that oxLDLs led to a decrease of activation-induced p65/p50 NF-kappa B heterodimer binding to DNA, whereas the presence of the constitutive nuclear form of p50 dimer was unchanged. This was correlated with an unchanged level of the active form of the cytosolic inhibitor protein I kappa B-alpha. Taken together, these observations suggest that the immunosuppressive effect of oxLDLs might operate via a dysregulation of the T-lymphocyte activation mechanisms.
引用
收藏
页码:269 / 274
页数:6
相关论文
共 44 条
  • [1] OXIDIZED LDL INDUCES TRANSCRIPTION FACTOR ACTIVATOR PROTEIN-1 BUT INHIBITS ACTIVATION OF NUCLEAR FACTOR-KAPPA-B IN HUMAN VASCULAR SMOOTH-MUSCLE CELLS
    ARES, MPS
    KALLIN, B
    ERIKSSON, P
    NILSSON, J
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (10) : 1584 - 1590
  • [2] The sphingomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation
    Auge, N
    Andrieu, N
    NegreSalvayre, A
    Thiers, JC
    Levade, T
    Salvayre, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) : 19251 - 19255
  • [3] BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
  • [4] Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion
    Brand, K
    Page, S
    Rogler, G
    Bartsch, A
    Brandl, R
    Knuechel, R
    Page, M
    Kaltschmidt, C
    Baeuerle, PA
    Neumeier, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (07) : 1715 - 1722
  • [5] Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein
    Brand, K
    Eisele, T
    Kreusel, U
    Page, M
    Page, S
    Haas, M
    Gerling, A
    Kaltschmidt, C
    Neumann, FJ
    Mackman, N
    Baeuerle, PA
    Walli, AK
    Neumeier, D
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (10) : 1901 - 1909
  • [6] Mildly oxidized low-density lipoproteins suppress the proliferation of activated CD4+ T-lymphocytes and their interleukin 2 receptor expression in vitro
    Caspar-Bauguil, S
    Saadawi, M
    Negre-Salvayre, A
    Thomsen, M
    Salvayre, R
    Benoist, H
    [J]. BIOCHEMICAL JOURNAL, 1998, 330 : 659 - 666
  • [7] Chiu B, 1997, CIRCULATION, V96, P2144
  • [8] T and B lymphocytes play a minor sole in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse
    Dansky, HM
    Charlton, SA
    Harper, MM
    Smith, JD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) : 4642 - 4646
  • [9] The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/-mice
    Daugherty, A
    Pure, E
    DelfelButteiger, D
    Chen, S
    Leferovich, J
    Roselaar, SE
    Rader, DJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) : 1575 - 1580
  • [10] CYCLOSPORINE TREATMENT REDUCES EARLY ATHEROSCLEROSIS IN THE CHOLESTEROL-FED RABBIT
    DREW, AF
    TIPPING, PG
    [J]. ATHEROSCLEROSIS, 1995, 116 (02) : 181 - 189